Tech Company Financing Transactions

MicroCHIPS Funding Round

MicroCHIPS closed a $13.4 million Series F funding round on 4/3/2007. Investors included Novartis BioVenture Fund, Boston Scientific Corporation and Flybridge Capital Partners.

Transaction Overview

Company Name
Announced On
4/3/2007
Transaction Type
Venture Equity
Amount
$13,400,000
Round
Series F
Investors

Novartis BioVenture Fund (Lead Investor) (Reinhard Ambros)

Boston Scientific Corporation (James Barry)

Flybridge Capital Partners (Michael Greeley)

Intersouth Partners

Medtronic (Stephen Oesterle)

Polaris Partners (Terry McGuire)

Proceeds Purpose
"This latest round of financing underscores the great market potential for MicroCHIPS' biosensing and drug delivery technology," stated John Santini, MicroCHIPS' CEO.

Company Information

Company Status
Private & Independent
Industry
Electronics
Mailing Address
128 Spring St. 310
Lexington, MA 02421
USA
Email Address
Overview
Microreservoirs are the core of our technology. Reservoirs can be incorportated into standalone devices that look like microchips, or they can be incorporated into an existing product to make it better. In all cases, reservoirs are at the center of our business.
Profile
MicroCHIPS LinkedIn Company Profile
Social Media
MicroCHIPS Company Twitter Account
Company News
MicroCHIPS News
Facebook
MicroCHIPS on Facebook
YouTube
MicroCHIPS on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Cheryl Blanchard
  Cheryl Blanchard LinkedIn Profile  Cheryl Blanchard Twitter Account  Cheryl Blanchard News  Cheryl Blanchard on Facebook
Chief Financial Officer
David Neafus
  David Neafus LinkedIn Profile  David Neafus Twitter Account  David Neafus News  David Neafus on Facebook
VP - Bus. Development
Nicolas Pacelli
  Nicolas Pacelli LinkedIn Profile  Nicolas Pacelli Twitter Account  Nicolas Pacelli News  Nicolas Pacelli on Facebook
VP - Human Resources
Paige Cochran
  Paige Cochran LinkedIn Profile  Paige Cochran Twitter Account  Paige Cochran News  Paige Cochran on Facebook
VP - Regulatory Affairs
Carol Pekar
  Carol Pekar LinkedIn Profile  Carol Pekar Twitter Account  Carol Pekar News  Carol Pekar on Facebook


 

 

Browse more venture capital transactions:

Prev: 4/3/2007: Syndax Pharmaceuticals venture capital transaction
Next: 4/3/2007: Baynote venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We report on tech company VC transactions. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary